Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Dietary Supplements × Lymphoid × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8 Head & Neck 4 Genitourinary 3 Breast 3 Thoracic 2 Tumor-Agnostic 1 Other hematologic neoplasm 1 Other 1 Lymphoid 1 Endocrine 1

Conditions

Interventions

Cyclophosphamide 45 Rituximab 32 Exercise 24 Blood Specimen Collection 23 fludarabine phosphate 21 Vincristine 20 Methotrexate 20 Radiotherapy 19 Cytarabine 19 Filgrastim 17 Whole-Body Irradiation 15 Prednisone 15 Peripheral Blood Stem Cell Transplantation 15 Methods 15 Melphalan 15 fludarabine 14 Etoposide 14 Doxorubicin 14 Cyclosporine 14 Educational Status 13 Antilymphocyte Serum 13 Dexamethasone 12 Busulfan 12 Mycophenolic Acid 11 Magnetic Resonance Spectroscopy 11 Early Intervention, Educational 10 Surveys and Questionnaires 9 Standard of Care 9 Prednisolone 9 Therapeutics 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05982223 2023-08-08

Integrative Medicine in Lymphoma Survivors

Bnai Zion Medical Center

Phase NA Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡